scispace - formally typeset
J

Janine Reichenbach

Researcher at Boston Children's Hospital

Publications -  93
Citations -  7915

Janine Reichenbach is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Chronic granulomatous disease & Immunodeficiency. The author has an hindex of 39, co-authored 91 publications receiving 7029 citations. Previous affiliations of Janine Reichenbach include University of Zurich & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense

TL;DR: It is shown that lipopolysaccharide from Gram-negative bacteria activates interleukin-5 (IL-5)- or interferon-γ–primed eosinophils to release mitochondrial DNA in a reactive oxygen species–dependent manner, but independent of eosInophil death, suggesting a previously undescribed mechanism of eOSinophil-mediated innate immune responses that might be crucial for maintaining the intestinal barrier function after inflammation-associated epithelial cell damage
Journal ArticleDOI

Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis

Luyan Liu, +70 more
TL;DR: Whole-exome sequencing reveals activating STAT1 mutations in some patients with autosomal dominant chronic mucocutaneous candidiasis disease.
Journal ArticleDOI

Restoration of NET formation by gene therapy in CGD controls aspergillosis

TL;DR: It is shown that reconstitution of NET formation by gene therapy in a patient with CGD restores neutrophil elimination of A nidulans conidia and hyphae and is associated with rapid cure of preexisting therapy refractory invasive pulmonary aspergillosis, underlining the role of functional NADPH oxidase in NET formation and antifungal activity.
Journal ArticleDOI

Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype.

TL;DR: Invasive infections, cerebral aneurysms, and cancers were the strongest predictors of poor outcome, and Circulating interleukin-17A-producing T-cell count was low for most (82%) but not all of the patients tested.
Journal ArticleDOI

Clinical Features and Outcome of Patients With IRAK-4 and MyD88 Deficiency

Capucine Picard, +69 more
- 01 Nov 2010 - 
TL;DR: IRAK-4 and MyD88 deficiencies predispose patients to recurrent life-threatening bacterial diseases, such as invasive pneumococcal disease in particular, in infancy and early childhood, with weak signs of inflammation.